Identification of nuclear matrix protein alterations associated with renal cell carcinoma

Journal of Urology

Volumn 159, Issue 4, 1998, Pages 1359-1363

  Konety, Badrinath R ^a   Nangia, Ajay K ^a   Nguyen, Thu Suong T ^a   Veitmeier, Barbara N ^a   Dhir, Rajiv ^a   Acierno, James S ^a   Becich, Michael J ^a   Hrebinko, Ronald L ^a   Getzenberg, Robert H ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b E1056 BST   (United States)

Author keywords

Diagnostic markers; Nuclear matrix proteins; Renal cell carcinoma

Indexed keywords

NUCLEAR PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL NUCLEUS MATRIX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MALIGNANT TRANSFORMATION; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0031894105     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63616-4     Document Type: Article

References (44)

1. Fuhrman, S. A., Lasky, L. C. and Limas, C.: Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol., 6: 663, 1982.
2. Skinner, D. G., Colvin, R. B., Vermillion, C. D., Pfister, R. C. and Leadbetter, W. F.: Diagnosis and management of renal cell carcinoma: a clinical and pathological study of 309 cases. Cancer, 28: 1165, 1971.
3. Pienta, K. J., Partin, A. W. and Coffey, D. S.: Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res., 49: 2525, 1989.
4. Fey, E. G., Bangs, P., Sparks, C. and Odgren, P.: The nuclear matrix: defining structural and functional roles. Crit. Rev. Eukaryotic Gene Expr., 1: 127, 1991.
5. Fey, E. G. and Penman, S.: Tumor promoters induce a specific morphological signature in the nuclear matrix-intermediate filament scaffold of Madin-Darby canine kidney (MDCK) cell colonies. Proc. Natl. Acad. Sci. USA, 81: 4409, 1984.
6. Hancock, R. and Boulakis, T.: Functional organization in the nucleus. Int. Rev. Cytol., 79: 165, 1982.
7. Vogelstein, B., Pardoll, D. M. and Coffey, D. S.: Supercoiled loops and eukaryotic DNA replication. Cell, 22: 79, 1980.
8. Getzenberg, R. H.: The nuclear matrix and the regulation of gene expression: tissue specificity. J. Cell. Biochem., 55: 22, 1994.
9. Zehnbauer, B. A. and Vogelstein, B.: Supercoiled loops and the organization of replication and transcription in eukaryotes. Bioessays, 2: 52, 1985.
10. Robinson, S. I., Small, D., Idzerda, R., Mcknight, G. S. and Vogelstein, B.: The association of transcriptionally active genes with the nuclear matrix of the chicken oviduct. Nucleic Acids Res., 11: 5113, 1983.
11. Small, D., Nelkin, B. and Vogelstein, B.: The association of transcribed genes with the nuclear matrix of Drosophila cells during heat shock. Nucleic Acids Res., 13: 2413, 1985.
12. Mirkovitch, J., Mirault, M-E. and Laemmli, U. K.: Organization of the higher order chromatic loop: specific DNA attachment sites on nuclear scaffold. Cell, 39: 223, 1984.
13. Buttyan, R. and Olsson, C. A.: Prediction of transcriptional activity based on gene association with the nuclear matrix. Biochem Biophys. Res. Commun., 138: 1334, 1986.
14. Ciejek, E. M., Tsai, M. J. and O'Malley, B. M.: Actively transcribed genes are associated with the nuclear matrix. Nature, 306: 607, 1983.
15. Stuurman, N., Meijne, A. M. L., van der Pool, A. J., de Jong, L., Van Driel, R. and Renswoude, J.: The nuclear matrix from cells of different origin. J. Biol. Chem., 265: 5460, 1990.
16. Fey, E. G. and Penman, S.: Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc. Natl. Acad. Sci. USA, 85: 121, 1988.
17. Getzenberg, R. H. and Coffey, D. S.: Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix proteins. Mol. Endocrinol., 4: 1336, 1990.
18. Stuurman, N., Van Driel, R., de Jong, L., Meijne, A. M. L. and Van Renswoude, J.: The protein composition of the nuclear matrix of murine P19 embryonal carcinoma cells is differentiation stage dependant. J. Exp. Cell Res., 180: 460, 1989.
19. Fey, E. G. and Penman, S.: The protein composition and morphology of the nuclear matrix-intermediate filament scaffold reflect cell type. Prog. Clin. Biol. Res., 249: 263, 1987.
20. Berezney, R., Basler, J., Hughes, B. B. and Kaplan, S. S.: Isolation and characterization of the nuclear matrix protein from Zajdela ascites hepatoma cells. Cancer Res., 39: 3031, 1979.
21. Partin, A. W., Getzenberg, R. H., CarMichael, M. J., Vindivich, D., Yoo, J., Epstein, J. I. and Coffey, D. S.: Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res., 53: 744, 1993.
22. Getzenberg, R. H., Konety, B. R., Oeler, T. A., Quigley, M. M., Hakam, A., Becich, M. J. and Bahnson, R. R.: Bladder cancer associated nuclear matrix proteins. Cancer Res., 56: 1690, 1996.
23. Khanuja, P. S., Lehr, J. E., Soule, H. D., Gehani, S. K., Noto, A. C., Choudhury, S., Chen, R. and Pienta, K. J.: Nuclear matrix proteins in normal and breast cancer cells. Cancer Res., 53: 3394, 1993.
24. Donat, T. L., Sakr, W., Lehr, J. E. and Pienta, K. J.: Unique nuclear matrix protein alterations in head and neck squamous cell carcinomas: intermediate biomarker candidates. Otolaryngology-Head & Neck Surgery, 114: 387, 1996.
25. Keese, S. K., Meneghini, M. D., Szaro, R. P. and Wu, Y-J.: Nuclear matrix proteins in human colon cancer. Proc. Natl. Acad. Sci. USA, 91: 1913, 1994.
26. Getzenberg, R. H., Pienta, K. J., Huang, E. Y. W. and Coffey, D. S.: Identification of nuclear proteins in the cancer and normal rat prostate. Cancer Res., 51: 6514, 1991.
27. Replogle-Schwab, T. S., Pienta, K. J. and Getzenberg, R. H.: The utilization of nuclear matrix proteins for cancer diagnosis. Crit. Rev. Eukar. Gene Express., 6: 103, 1996.
28. Williams, R. D., Elliot, A. Y., Stein, N. and Fraley, E. E.: In vitro cultivation of human renal cell cancer II. Characterization of cell lines. In Vitro, 14:779, 1978.
29. Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H. and Parks, W. P.: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst., 51: 1417, 1973.
30. Fey, E. G. and Penman, S.: Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: three-dimensional organization and protein composition. J. Cell. Biol., 98: 1973, 1988.
31. Patton, W. F., Pluskal, M. G., Skea, W. M., Buecker, J. L., Lopez, M. F., Zimmerman, R., Belanger, L. M. and Hatch, P. D.: Development of a dedicated two-dimensional gel electrophoresis system that provides optimal pattern reproducibility and polypeptide resolution. Biotechniques, 8: 518, 1990.
32. Wray, W., Boulakis, T., Wray, V. and Hancock R.: Silver staining of proteins in polyacrylamide gels. Anal. Biochem., 118: 197, 1981.
33. Thompson, I. M. and Peek, M.: Improvement in survival of patients with renal cell carcinoma the role of the serendipitously detected tumor. J. Urol., 140: 487, 1988.
34. Bander, N. H.: Monoclonal antibodies to renal cancer antigens. Semin. Urol., 7: 264, 1989.
35. Vessella, R. L.: Radioimmunoconjugates in renal cell carcinoma. In: Immunotherapy of Renal Cell arcinoma. Edited by F. M. S. Debruyne, R. M. Bukowski and J. R. Pontes. Heidelberg, Germany: Springer-Verlag, 38-46, 1991.
36. Vessella, R. L., Chiou, R. K. and Grund, F. M.: Renal cell carcinoma (RCC) phase I-II trials with I-131 labeled mouse monoclonal antibody A6H: imaging and pharmacokinetic studies (abstr 1525). Proc. Am. Assoc. Cancer Res., 28: 480, 1987.
37. Vessella, R. L., Moon, T. D., Chiou, R. K., Nowak, J. A., Arfman, E, W., Palme, D. F., Peterson, G. A. and Lange, P. H.: Monoclonal antibodies to renal cell carcinoma: recognition of shared and restricted tissue antigens. Cancer Res., 45: 6131, 1985.
38. Oosterwijk, E., Ruiter, D. J., Hoedemaeker, P. H. J., Pauwels, E. K., Jonas, U., Zwartendijk, J. and Warnaar, S. O.: Monoclonal antibody G250 recognizes a determinant present in renal cell carcinoma and absent from normal kidney. Int. J. Cancer, 38: 489, 1986.
39. Oosterwijk, E., Bander, N. H., Divgi, C. R., Welt, S., Wakka, J. C., Finn, R. D., Carswell, E. A., Larson, S. M., Warnaar, S. O., Fleuren, G. J., Oettgen, H. F. and Old, J.: Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. J. Clin. Oncol., 11: 738, 1993.
40. Miller, T. E., Beausang, L. A., Winchell, L. F. and Lidgard, G. P.: Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res., 52: 422, 1992.
41. Cronin, K. J., Williams, N. N., Kerin, M. J., Creagh, T. A., Dervan, P. A., Smith, J. M. and Fitzpatrick, J. M.: Proliferating cell nuclear antigen: a new prognostic indicator in renal cell carcinoma. J. Urol., 152: 834, 1994.
42. Delahunt, B., Bethwaite, P. B., Thornton, A. and Ribas, J. L.: Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Cancer, 75: 2714, 1995.
43. Verheijen, R., Kuijpers, H. J. H., Schlingemann, R. O., Boehmer, A. L. M., van Driel, R., Brakenhoff, G. J. and Ramaekers, F. C. S.: Ki-67 detects a nuclear matrix associated proliferation-related antigen. J. Cell Sci., 92: 123, 1989.
44. Oberhammer, F. A., Hochegger, K., Froschl. G., Tiefenbacher, R. and Pavelka, M.: Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase. J. Cell Biol., 126: 827, 1994.